B cell depletion therapy exacerbates murine primary biliary cirrhosis
about
Xenobiotics and loss of tolerance in primary biliary cholangitisIdentification of potential cytokine pathways for therapeutic intervention in murine primary biliary cirrhosisLiver immunology.Pathological features of new animal models for primary biliary cirrhosis.Environmental Basis of Autoimmunity.Plasma cells and the chronic nonsuppurative destructive cholangitis of primary biliary cirrhosis.αβ TCR⁺ T cells, but not B cells, promote autoimmune keratitis in b10 mice lacking γδ T cellsTransient depletion of B cells in young mice results in activation of regulatory T cells that inhibit development of autoimmune disease in adultsInterleukin-10 From Marginal Zone Precursor B-Cell Subset Is Required for Costimulatory Blockade-Induced Transplantation Tolerance.Advances in pharmacotherapy for primary biliary cirrhosis.B cell depletion in treating primary biliary cirrhosis: pros and consIL-10-producing regulatory B cells in the pathogenesis of chronic hepatitis B virus infectionGenome-Wide Association Studies in Primary Biliary Cirrhosis.Role of autoimmunity in primary biliary cirrhosis.The immunopathology of liver granulomas in primary biliary cirrhosis.A case of primary biliary cirrhosis that progressed rapidly after treatment involving rituximab.Dysregulation of peritoneal cavity B1a cells and murine primary biliary cholangitis.Immunological orchestration of liver fibrosis.Animal models in primary biliary cirrhosis and primary sclerosing cholangitis.Novel therapeutic targets in primary biliary cirrhosis.Etiopathogenesis of primary biliary cirrhosis: an overview of recent developments.It is time to change primary biliary cirrhosis (PBC): New nomenclature from "cirrhosis" to "cholangitis", and upcoming treatment based on unveiling pathology.Recruitment mechanisms of primary and malignant B cells to the human liver.Animal models of primary biliary cirrhosis.B cells expressing CD11b effectively inhibit CD4+ T-cell responses and ameliorate experimental autoimmune hepatitis in mice.Biochemical and immunologic effects of rituximab in patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid.Hepatic B cells are readily activated by Toll-like receptor-4 ligation and secrete less interleukin-10 than lymphoid tissue B cells.From pathogenesis to novel therapies in the treatment of primary biliary cholangitis.B-cell depletion with rituximab in patients with primary biliary cirrhosis refractory to ursodeoxycholic acid.The role of natural killer (NK) and NK T cells in the loss of tolerance in murine primary biliary cirrhosis.Altered Distribution of Peripheral Blood Maturation-Associated B-Cell Subsets in Chronic Alcoholism.Heritability enrichment of specifically expressed genes identifies disease-relevant tissues and cell types.Primary biliary cholangitis: new treatments for an old disease.
P2860
Q26772312-AAA13BE3-58EC-4393-BBFB-270ACE769997Q28533202-4F5A78CA-42CF-48E5-B8EA-357C283C7A21Q34359990-99CD5AE3-5D26-461B-8ED7-142F895EDFB3Q35203353-AD615710-0542-4633-A5F8-999A277A0EEEQ35638839-9C556174-5BFF-4495-A244-DFEA8D024A0CQ35736729-FADB15B2-427A-4AAD-A8D4-D86209C3C83CQ35797232-66BCF166-1AB4-4B84-BDA9-B7E7C19120DDQ35852020-8AF81F73-38B6-4BA3-B6EF-DFBC9742B465Q36001633-9358578D-5CF7-4BDD-BE0A-3B03C3329D8AQ36116022-500383C4-2907-4A70-8407-1F331563C0E3Q36166941-6E36BC92-87B1-4DEF-9C23-7CF3E041BC04Q36345904-3668D424-9CE0-4827-BD08-CAFDA50D310FQ36383011-DBF56E91-F986-4671-9D99-91E20BD0F162Q36529131-430B4AD6-2766-445C-B2E3-AB70D7C3F101Q36573783-0D2C1F8A-F02E-4A51-9638-456CDD693DB9Q36851472-C6B3F50E-B7EA-4673-AF91-AA142C844F2AQ37317145-2E1EFA3D-E65A-4613-B5BF-EB08390D76D0Q38018539-6F64CB47-5D3B-4C65-80A2-49C1F9A2D6A7Q38244716-657358FE-063C-4B18-97FE-4C5D0D0309B2Q38342107-3D20F274-CA48-45E2-A3FC-60409F02F2CBQ38552201-50AF9A47-7BDD-4AAE-AAC1-0D7DDFDA2C1DQ38620686-87ED5256-3078-4FB4-A6B0-C4B208518441Q39363836-2C30E363-9869-4430-8364-E15A4864F801Q41221983-0DA2309E-DBA8-411F-A38A-D38B72C3A8C4Q41551818-A42E27B1-4B1E-40E1-ADD1-1EF05D711907Q42620850-B3176A88-E220-48A7-A514-8574098987A7Q43585852-AAD87B2F-2EEE-4EFC-8747-A0CC24BC5A62Q46135644-09B50525-9311-4C0C-B3E9-032F0E310FA6Q46484331-97923D91-95DC-43F2-86FD-94B6E61C407FQ47877699-80F64A9A-B883-493B-B4CF-F03DE4E5D715Q50724315-EE52F305-A0E8-4291-A2B1-8EB8D67D6FC6Q52720499-C5110CC7-70BE-41F5-96A5-7C86D6A415BFQ54390436-4CDEFF02-F22A-4AD2-A212-49346EEFCABD
P2860
B cell depletion therapy exacerbates murine primary biliary cirrhosis
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
B cell depletion therapy exacerbates murine primary biliary cirrhosis
@ast
B cell depletion therapy exacerbates murine primary biliary cirrhosis
@en
B cell depletion therapy exacerbates murine primary biliary cirrhosis
@nl
type
label
B cell depletion therapy exacerbates murine primary biliary cirrhosis
@ast
B cell depletion therapy exacerbates murine primary biliary cirrhosis
@en
B cell depletion therapy exacerbates murine primary biliary cirrhosis
@nl
prefLabel
B cell depletion therapy exacerbates murine primary biliary cirrhosis
@ast
B cell depletion therapy exacerbates murine primary biliary cirrhosis
@en
B cell depletion therapy exacerbates murine primary biliary cirrhosis
@nl
P2093
P2860
P50
P356
P1433
P1476
B cell depletion therapy exacerbates murine primary biliary cirrhosis
@en
P2093
Amy Dhirapong
Fu-Tong Liu
Guo-Xiang Yang
John C Cambier
Keith Lindor
Koichi Tsuneyama
Marilyn Kehry
Robert Dunn
Thomas A Packard
P2860
P304
P356
10.1002/HEP.24044
P407
P577
2010-12-28T00:00:00Z